These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 18254090)
21. Effects of Self-Selected Exercise on Strength in Charcot-Marie-Tooth Disease Subtypes. Djordjevic D; Fell S; Baker S Can J Neurol Sci; 2017 Sep; 44(5):572-576. PubMed ID: 28669366 [TBL] [Abstract][Full Text] [Related]
22. Systematic review of exercise for Charcot-Marie-Tooth disease. Sman AD; Hackett D; Fiatarone Singh M; Fornusek C; Menezes MP; Burns J J Peripher Nerv Syst; 2015 Dec; 20(4):347-62. PubMed ID: 26010435 [TBL] [Abstract][Full Text] [Related]
23. Sensory manifestations in Charcot-Marie-Tooth disease. Gemignani F; Melli G; Alfieri S; Inglese C; Marbini A J Peripher Nerv Syst; 2004 Mar; 9(1):7-14. PubMed ID: 14871449 [TBL] [Abstract][Full Text] [Related]
24. Interventions for increasing ankle range of motion in patients with neuromuscular disease. Rose KJ; Burns J; Wheeler DM; North KN Cochrane Database Syst Rev; 2010 Feb; (2):CD006973. PubMed ID: 20166090 [TBL] [Abstract][Full Text] [Related]
25. Comparison of gait patterns and functional measures between Charcot-Marie-Tooth disease type I and II in children to young adults. Pogemiller K; Garibay E; Pierz K; Acsadi G; Õunpuu S Gait Posture; 2020 Mar; 77():236-242. PubMed ID: 32062403 [TBL] [Abstract][Full Text] [Related]
26. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Vogel AP; Folker J; Poole ML Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008953. PubMed ID: 25348587 [TBL] [Abstract][Full Text] [Related]
29. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Pareyson D; Reilly MM; Schenone A; Fabrizi GM; Cavallaro T; Santoro L; Vita G; Quattrone A; Padua L; Gemignani F; Visioli F; Laurà M; Radice D; Calabrese D; Hughes RA; Solari A; ; Lancet Neurol; 2011 Apr; 10(4):320-8. PubMed ID: 21393063 [TBL] [Abstract][Full Text] [Related]
30. Interventions for preventing neuropathy caused by cisplatin and related compounds. Albers JW; Chaudhry V; Cavaletti G; Donehower RC Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD005228. PubMed ID: 24687190 [TBL] [Abstract][Full Text] [Related]
31. Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease. Smith CA; Chetlin RD; Gutmann L; Yeater RA; Alway SE Muscle Nerve; 2006 Nov; 34(5):586-94. PubMed ID: 16881064 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Quinlivan R; Martinuzzi A; Schoser B Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD003458. PubMed ID: 25391139 [TBL] [Abstract][Full Text] [Related]
33. Reliability and validity of the CMT neuropathy score as a measure of disability. Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348 [TBL] [Abstract][Full Text] [Related]
34. Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT. Prada V; Zuccarino R; Schenone C; Mennella G; Grandis M; Shy ME; Schenone A Neurol Sci; 2022 Apr; 43(4):2759-2764. PubMed ID: 34613504 [TBL] [Abstract][Full Text] [Related]
35. Drugs for discoid lupus erythematosus. Jessop S; Whitelaw DA; Grainge MJ; Jayasekera P Cochrane Database Syst Rev; 2017 May; 5(5):CD002954. PubMed ID: 28476075 [TBL] [Abstract][Full Text] [Related]
36. Exercise for people with peripheral neuropathy. White CM; Pritchard J; Turner-Stokes L Cochrane Database Syst Rev; 2004 Oct; (4):CD003904. PubMed ID: 15495069 [TBL] [Abstract][Full Text] [Related]